These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

273 related items for PubMed ID: 22815323

  • 1. Immediate postoperative inflammatory response predicts long-term outcome in lung-transplant recipients.
    Hall DJ, Baz M, Daniels MJ, Staples ED, Klodell CT, Moldawer LL, Beaver TM.
    Interact Cardiovasc Thorac Surg; 2012 Oct; 15(4):603-7. PubMed ID: 22815323
    [Abstract] [Full Text] [Related]

  • 2. Is transplant operation important in determining posttransplant risk of bronchiolitis obliterans syndrome in lung transplant recipients?
    Hadjiliadis D, Davis RD, Palmer SM.
    Chest; 2002 Oct; 122(4):1168-75. PubMed ID: 12377838
    [Abstract] [Full Text] [Related]

  • 3. The Role of TGF-β in the Association Between Primary Graft Dysfunction and Bronchiolitis Obliterans Syndrome.
    DerHovanessian A, Weigt SS, Palchevskiy V, Shino MY, Sayah DM, Gregson AL, Noble PW, Palmer SM, Fishbein MC, Kubak BM, Ardehali A, Ross DJ, Saggar R, Lynch JP, Elashoff RM, Belperio JA.
    Am J Transplant; 2016 Feb; 16(2):640-9. PubMed ID: 26461171
    [Abstract] [Full Text] [Related]

  • 4. Donor factors are associated with bronchiolitis obliterans syndrome after lung transplantation.
    Hennessy SA, Hranjec T, Swenson BR, Kozower BD, Jones DR, Ailawadi G, Kron IL, Lau CL.
    Ann Thorac Surg; 2010 May; 89(5):1555-62. PubMed ID: 20417777
    [Abstract] [Full Text] [Related]

  • 5. Survival after bronchiolitis obliterans syndrome among bilateral lung transplant recipients.
    Finlen Copeland CA, Snyder LD, Zaas DW, Turbyfill WJ, Davis WA, Palmer SM.
    Am J Respir Crit Care Med; 2010 Sep 15; 182(6):784-9. PubMed ID: 20508211
    [Abstract] [Full Text] [Related]

  • 6. Self-reactive antibodies associated with bronchiolitis obliterans syndrome subtype of chronic lung allograft dysfunction.
    Kaza V, Zhu C, Terada LS, Wang L, Torres F, Bollineni S, Mohanka M, Banga A, Joerns J, Mohanakumar T, Li QZ.
    Hum Immunol; 2021 Jan 15; 82(1):25-35. PubMed ID: 33129576
    [Abstract] [Full Text] [Related]

  • 7. The Impact of Alemtuzumab and Basiliximab Induction on Patient Survival and Time to Bronchiolitis Obliterans Syndrome in Double Lung Transplantation Recipients.
    Furuya Y, Jayarajan SN, Taghavi S, Cordova FC, Patel N, Shiose A, Leotta E, Criner GJ, Guy TS, Wheatley GH, Kaiser LR, Toyoda Y.
    Am J Transplant; 2016 Aug 15; 16(8):2334-41. PubMed ID: 26833657
    [Abstract] [Full Text] [Related]

  • 8. Pretransplant serum human chitinase-like glycoprotein YKL-40 concentrations independently predict bronchiolitis obliterans development in lung transplant recipients.
    Jaksch P, Taghavi S, Klepetko W, Salama M.
    J Thorac Cardiovasc Surg; 2014 Jul 15; 148(1):273-81. PubMed ID: 24685381
    [Abstract] [Full Text] [Related]

  • 9. Bronchiolitis obliterans syndrome-free survival after lung transplantation: An International Society for Heart and Lung Transplantation Thoracic Transplant Registry analysis.
    Kulkarni HS, Cherikh WS, Chambers DC, Garcia VC, Hachem RR, Kreisel D, Puri V, Kozower BD, Byers DE, Witt CA, Alexander-Brett J, Aguilar PR, Tague LK, Furuya Y, Patterson GA, Trulock EP, Yusen RD.
    J Heart Lung Transplant; 2019 Jan 15; 38(1):5-16. PubMed ID: 30391193
    [Abstract] [Full Text] [Related]

  • 10. Effect of adherence to home spirometry on bronchiolitis obliterans and graft survival after lung transplantation.
    Kugler C, Fuehner T, Dierich M, DeWall C, Haverich A, Simon A, Welte T, Gottlieb J.
    Transplantation; 2009 Jul 15; 88(1):129-34. PubMed ID: 19584692
    [Abstract] [Full Text] [Related]

  • 11. Soluble CD59 is a Novel Biomarker for the Prediction of Obstructive Chronic Lung Allograft Dysfunction After Lung Transplantation.
    Budding K, van de Graaf EA, Kardol-Hoefnagel T, Kwakkel-van Erp JM, Luijk BD, Oudijk ED, van Kessel DA, Grutters JC, Hack CE, Otten HG.
    Sci Rep; 2016 May 24; 6():26274. PubMed ID: 27215188
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Early posttransplant inflammation promotes the development of alloimmunity and chronic human lung allograft rejection.
    Bharat A, Narayanan K, Street T, Fields RC, Steward N, Aloush A, Meyers B, Schuessler R, Trulock EP, Patterson GA, Mohanakumar T.
    Transplantation; 2007 Jan 27; 83(2):150-8. PubMed ID: 17264811
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Non-immune acute graft injury after lung transplantation and the risk of subsequent bronchiolitis obliterans syndrome (BOS).
    Fisher AJ, Wardle J, Dark JH, Corris PA.
    J Heart Lung Transplant; 2002 Nov 27; 21(11):1206-12. PubMed ID: 12431494
    [Abstract] [Full Text] [Related]

  • 17. Antibodies to self-antigens predispose to primary lung allograft dysfunction and chronic rejection.
    Bharat A, Saini D, Steward N, Hachem R, Trulock EP, Patterson GA, Meyers BF, Mohanakumar T.
    Ann Thorac Surg; 2010 Oct 27; 90(4):1094-101. PubMed ID: 20868794
    [Abstract] [Full Text] [Related]

  • 18. The Impact of Donor-Recipient Human Leukocyte Antigen Matching on Bronchiolitis Obliterans-Free Survival Among Lung Transplant Recipients With Connective Tissue Diseases.
    Courtwright AM, Diamond JM, Sandorfi N, Goldberg HJ.
    Clin Transplant; 2024 Aug 27; 38(8):e15426. PubMed ID: 39136242
    [Abstract] [Full Text] [Related]

  • 19. Donor clara cell secretory protein polymorphism is a risk factor for bronchiolitis obliterans syndrome after lung transplantation.
    Bourdin A, Mifsud NA, Chanez B, McLean C, Chanez P, Snell G, Kotsimbos TC.
    Transplantation; 2012 Sep 27; 94(6):652-8. PubMed ID: 22902791
    [Abstract] [Full Text] [Related]

  • 20. Impact of immediate primary lung allograft dysfunction on bronchiolitis obliterans syndrome.
    Daud SA, Yusen RD, Meyers BF, Chakinala MM, Walter MJ, Aloush AA, Patterson GA, Trulock EP, Hachem RR.
    Am J Respir Crit Care Med; 2007 Mar 01; 175(5):507-13. PubMed ID: 17158279
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.